When Can We Expect A Profit From Zepp Health Corporation (NYSE:ZEPP)?

Zepp Health Corporation (NYSE:ZEPP) is possibly approaching a major achievement in its business, so we would like to shine some light on the company. Zepp Health Corporation operates as a smart wearable and health technology company worldwide. The US$61m market-cap company posted a loss in its most recent financial year of US$40m and a latest trailing-twelve-month loss of US$44m leading to an even wider gap between loss and breakeven. As path to profitability is the topic on Zepp Health's investors mind, we've decided to gauge market sentiment. Below we will provide a high-level summary of the industry analysts’ expectations for the company.

We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.

Zepp Health is bordering on breakeven, according to some American Electronic analysts. They expect the company to post a final loss in 2026, before turning a profit of US$12m in 2027. Therefore, the company is expected to breakeven just over a year from today. What rate will the company have to grow year-on-year in order to breakeven on this date? Using a line of best fit, we calculated an average annual growth rate of 162%, which is rather optimistic! If this rate turns out to be too aggressive, the company may become profitable much later than analysts predict.

Given this is a high-level overview, we won’t go into details of Zepp Health's upcoming projects, but, bear in mind that by and large a high forecast growth rate is not unusual for a company that is currently undergoing an investment period.

See our latest analysis for Zepp Health

One thing we would like to bring into light with Zepp Health is its relatively high level of debt. Typically, debt shouldn’t exceed 40% of your equity, which in Zepp Health's case is 72%. A higher level of debt requires more stringent capital management which increases the risk around investing in the loss-making company.

Next Steps:

There are too many aspects of Zepp Health to cover in one brief article, but the key fundamentals for the company can all be found in one place – Zepp Health's company page on Simply Wall St. We've also put together a list of key aspects you should further research:

1. Valuation: What is Zepp Health worth today? Has the future growth potential already been factored into the price? The intrinsic value infographic in our free research report helps visualize whether Zepp Health is currently mispriced by the market.
2. Management Team: An experienced management team on the helm increases our confidence in the business – take a look at who sits on Zepp Health’s board and the CEO’s background.
3. Other High-Performing Stocks: Are there other stocks that provide better prospects with proven track records? Explore our free list of these great stocks here.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.